Evidence map›Paper›PMID 23365694›Full record

ArticlePloS one2013

Age-associated changes in monocyte and innate immune activation markers occur more rapidly in HIV infected women.

Genevieve E Martin, Maelenn Gouillou, Anna C Hearps, Thomas A Angelovich, Allen C Cheng, Fiona Lynch, Wan-Jung Cheng, Geza Paukovics, Clovis S Palmer, Richard M Novak and 3 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed, 1 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 1 synthesis or guideline pooled it, 119 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Genevieve E MartinCentre for Virology, Burnet Institute, Melbourne, Australia.
Maelenn Gouillou
Anna C Hearps
Thomas A Angelovich
Allen C Cheng
Fiona Lynch
Wan-Jung Cheng
Geza Paukovics
Clovis S Palmer
Richard M Novak
Anthony Jaworowski
Alan L Landay
Suzanne M Crowe
Burnet Institute · AUMonash University · AUUniversity of Illinois Chicago · USRush University Medical Center · USThe Alfred Hospital · AUUNSW Sydney · AU

Funding

Tissue Culture and Virology Laboratory CoreP01AI082971 · NIAID · RUSH UNIVERSITY MEDICAL CENTER · PI LANDAY, ALAN L · 2009 to 2013
$11.2M
DevelopmentalP30AI082151 · NIAID · RUSH UNIVERSITY MEDICAL CENTER · PI LANDAY, ALAN L · 2009 to 2014
$4.6M
NIAID NIH HHS P01 AI082971NIAID NIH HHS P01 [AI082971NIAID NIH HHS P30 AI082151NIAID NIH HHS P30-AI082151
6 · The paper itself

Abstract

backgroundAging is associated with immune dysfunction and the related development of conditions with an inflammatory pathogenesis. Some of these immune changes are also observed in HIV infection, but the interaction between immune changes with aging and HIV infection are unknown. Whilst sex differences in innate immunity are recognized, little research into innate immune aging has been performed on women.

methodsThis cross-sectional study of HIV positive and negative women used whole blood flow cytometric analysis to characterize monocyte and CD8(+) T cell subsets. Plasma markers of innate immune activation were measured using standard ELISA-based assays.

resultsHIV positive women exhibited elevated plasma levels of the innate immune activation markers CXCL10 (p<0.001), soluble CD163 (sCD163, p = 0.001), sCD14 (p = 0.022), neopterin (p = 0.029) and an increased proportion of CD16(+) monocytes (p = 0.009) compared to uninfected controls. Levels of the innate immune aging biomarkers sCD163 and the proportion of CD16(+) monocytes were equivalent to those observed in HIV negative women aged 14.5 and 10.6 years older, respectively. CXCL10 increased with age at an accelerated rate in HIV positive women (p = 0.002) suggesting a synergistic effect between HIV and aging on innate immune activation. Multivariable modeling indicated that age-related increases in innate immune biomarkers CXCL10 and sCD163 are independent of senescent changes in CD8(+) T lymphocytes.

conclusionsQuantifying the impact of HIV on immune aging reveals that HIV infection in women confers the equivalent of a 10-14 year increase in the levels of innate immune aging markers. These changes may contribute to the increased risk of inflammatory age-related diseases in HIV positive women.

Indexed as

Immunity, InnateAdultAge FactorsAgingAntigens, CDAntigens, Differentiation, MyelomonocyticBiomarkersCase-Control StudiesCD163 AntigenCD8-Positive T-LymphocytesChemokine CXCL10Cross-Sectional StudiesFemaleGPI-Linked ProteinsHIVHIV InfectionsAntigens, CDAntigens, Differentiation, MyelomonocyticBiomarkersCD163 AntigenChemokine CXCL10CXCL10 protein, humanFCGR3B protein, humanGPI-Linked ProteinsLipopolysaccharide ReceptorsNeopterinReceptors, Cell SurfaceReceptors, IgG

Identifiers

PMID23365694
PMCPMC3554695
OpenAlexW2044460884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.